SynthaverseS.A.Active

Manufacture of pharmaceutical preparations

KRS: 0000373032 NIP: 7122591951 REGON: 43124964500000

Overview

Registry date
2010-12-13
Share capital
$2,046,747.03
Activity description

Synthaverse is a Polish biotechnology company that has been operating since 1944, specializing in the development of immunotherapy solutions for various medical fields, including oncology, urology, gynecology, and tuberculosis treatment. The company offers products such as ONKO BCG, DAVOSTER, and DISTREPTAZA, aimed at supporting patients and the medical community.

Registered address
Uniwersytecka 10, 20-029 Lublin, Poland
Website
synthaverse.plWebsite inactive
Email
Email address current
Electronic delivery address
AE:PL-72596-86698-BCSGS-29

Accounts

Registered as a VAT taxpayer on 2003-09-30.Active

Authorized Representatives

Ownership

FAQ

Last updated: 2026-07-09